Putting Growth Capital to Work in Philadelphia
On average, Safeguard Scientifics evaluates more than a thousand business plans each year—that’s 20 business plans per week. Last year, we chose to partner with…
Posted by
On average, Safeguard Scientifics evaluates more than a thousand business plans each year—that’s 20 business plans per week. Last year, we chose to partner with…
Posted by
We’re pleased to welcome a new member to our board of directors, Dr. Keith B. Jarrett, who was appointed to our board yesterday following the…
Posted by
Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious.…
Posted by
At Safeguard Scientifics, we offer our partner companies quality resources to promote their growth and help them recruit strong management teams for their future. We…
Posted by
The past 12 months have exciting at Safeguard Scientifics. In December of 2010, partner companies Clarient and Avid Radiopharmaceuticals were both acquired by giants in…
Posted by
Here at Safeguard Scientifics, we provide capital to growth-stage companies in both the life sciences and technology. It’s important to note, however, that Safeguard provides…
Posted by
Last week our own Gary J. Kurtzman, MD, Senior Vice President and Managing Director in the Safeguard Life Sciences Group, participated on a panel at…
Posted by
The IPO Task Force unveiled a new effort to ease the IPO road for emerging companies in its report, “Rebuilding the IPO On-Ramp.” The report…
Posted by
Safeguard Scientifics Investor Day 2011 is right around the corner. Join executives from Safeguard Scientifics and select partner companies at The Yale Club of New York…
Posted by